Hormographiella aspergillata: An emerging mould in acute leukaemia patients?

Clinical Microbiology and Infection

Volumn 17, Issue 2, 2011, Pages 273-277

  Conen, A ^a   Weisser, M ^b   Hohler, D ^c   Frei, R ^c   Stern, M ^d  

^a CANTONAL HOSPITAL AARAU   (Switzerland)

^b Hospital Epidemiology   (Switzerland)

^c Clinical Microbiology Laboratory   (Switzerland)

^d UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Chemotherapy; Leukaemia; Mould infection; Non Aspergillus mould; Stem cell transplantation

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; ANTINEOPLASTIC AGENT; CASPOFUNGIN; MELPHALAN; METHYLPREDNISOLONE; POSACONAZOLE; VALACICLOVIR; VORICONAZOLE;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ALLOGENEIC PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; ANTIFUNGAL SUSCEPTIBILITY; ANTIMICROBIAL THERAPY; ARTICLE; AUTOPSY; BRAIN INFECTION; CANCER PATIENT; CASE REPORT; CEREBELLUM HEMORRHAGE; COMPUTER ASSISTED TOMOGRAPHY; CORD BLOOD STEM CELL TRANSPLANTATION; CORTICOSTEROID THERAPY; COUGHING; DRUG BLOOD LEVEL; DRUG MEGADOSE; DRUG SUBSTITUTION; FEBRILE NEUTROPENIA; FEMALE; FUNGUS CULTURE; GRAFT VERSUS HOST REACTION; HERPES SIMPLEX; HISTOPATHOLOGY; HORMOGRAPHIELLA ASPERGILLATA; HORMOGRAPHIELLA ASPERGILLATA INFECTION; HUMAN; HUMAN TISSUE; LIVER FUNCTION TEST; LOADING DRUG DOSE; LUNG ASPERGILLOSIS; LUNG INFILTRATE; LUNG LAVAGE; LUNG MYCOSIS; LUNG NODULE; LUNG PARENCHYMA; LUNG RESECTION; MALE; MINIMUM INHIBITORY CONCENTRATION; MOULD; MULTIPLE CYCLE TREATMENT; MYELOABLATIVE CONDITIONING; PRIORITY JOURNAL; SIDE EFFECT; SYSTEMIC MYCOSIS; SYSTEMIC THERAPY; TREATMENT OUTCOME; VIDEO ASSISTED THORACOSCOPIC SURGERY;

ASPERGILLUS;

EID: 78650911883     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2010.03266.x     Document Type: Article

References (16)

1. Marr KA, Carter RA, Crippa F, Wald A, Corey L. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis 2002; 34: 909-917.
2. Lagrou K, Massonet C, Theunissen K et al. Fatal pulmonary infection in a leukaemic patient caused by Hormographiella aspergillata. J Med Microbiol 2005; 54: 685-688.
3. Verweij PE, van Kasteren M, van de Nes J, de Hoog GS, de Pauw BE, Meis JF. Fatal pulmonary infection caused by the basidiomycete Hormographiella aspergillata. J Clin Microbiol 1997; 35: 2675-2678.
4. Surmont I, Van Aelst F, Verbanck J, De Hoog GS. A pulmonary infection caused by Coprinus cinereus (Hormographiella aspergillata) diagnosed after a neutropenic episode. Med Mycol 2002; 40: 217-219.
5. Nenoff P, Friedrich T, Schwenke H, Mierzwa M, Horn LC, Haustein UF. Rare fatal simultaneous mould infection of the lung caused by Aspergillus flavus and the Basidiomycete coprinus sp. in a leukemic patient. J Med Vet Mycol 1997; 35: 65-69.
6. Abuali MM, Posada R, Del Toro G et al. Rhizomucor variabilis var. regularior and Hormographiella aspergillata infections in a leukemic bone marrow transplant recipient with refractory neutropenia. J Clin Microbiol 2009; 47: 4176-4179.
7. Hall L, Wohlfiel S, Roberts GD. Experience with the microseq d2 large-subunit ribosomal DNA sequencing kit for identification of filamentous fungi encountered in the clinical laboratory. J Clin Microbiol 2004; 42: 622-626.
8. CLSI. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi: approved standard., 2nd edn. Wayne, PA: Institute CaLS, 2008.
9. De Pauw B, Walsh TJ, Donnelly JP et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) consensus group. Clin Infect Dis. 2008; 46: 1813-1821.
10. Fluckiger U, Marchetti O, Bille J et al. Treatment options of invasive fungal infections in adults. Swiss Med Wkly 2006; 136: 447-463.
11. Dignani MC, Anaissie E. Human fusariosis. Clin Microbiol Infect 2004; 10 (suppl 1): 67-75.
12. Reichenberger F, Habicht J, Matt P et al. Diagnostic yield of bronchoscopy in histologically proven invasive pulmonary aspergillosis. Bone Marrow Transplant 1999; 24: 1195-1199.
13. Reichenberger F, Habicht J, Kaim A et al. Lung resection for invasive pulmonary aspergillosis in neutropenic patients with hematologic diseases. Am J Respir Crit Care Med 1998; 158: 885-890.
14. Gene J, Guillamon JM, Guarro J, Pujol I, Ulfig K. Molecular characterization, relatedness and antifungal susceptibility of the Basidiomycetous hormographiella species and coprinus cinereus from clinical and environmental sources. Antonie Van Leeuwenhoek 1996; 70: 49-57.
15. Gonzalez GM, Sutton DA, Thompson E, Tijerina R, Rinaldi MG. In vitro activities of approved and investigational antifungal agents against 44 clinical isolates of Basidiomycetous fungi. Antimicrob Agents Chemother 2001; 45: 633-635.
16. Diekema DJ, Messer SA, Hollis RJ, Jones RN, Pfaller MA. Activities of caspofungin, itraconazole, posaconazole, ravuconazole, voriconazole, and amphotericin B against 448 recent clinical isolates of filamentous fungi. J Clin Microbiol 2003; 41: 3623-3626.